Stocksigma LogoStocksigma Logo

Aakaar Medical Technologies Reports Strong H1 FY27 Turnaround; Approves ESOPs and Leadership Addition

Aakaar Medical Technologies reported standalone revenue from operations of ₹4,372.34 lacs for the half year ended 30th Sep'26, up 72.65% YoY from ₹2,532.49

Aakaar Medical Technologies Reports Strong H1 FY27 Turnaround; Approves ESOPs and Leadership Addition

Aakaar Medical Technologies Ltd · Outcome · 30 Oct 2026, 11:18 pm

Aakaar Medical Technologies Reports Strong H1 FY27 Turnaround; Approves ESOPs and Leadership Addition Aakaar Medical Technologies reported standalone revenue from operations of ₹4,372.34 lacs for the half year ended 30th Sep'26, up 72.65% YoY from ₹2,532.49 lacs. The company turned profitable with a net profit of ₹354.09 lacs compared to a net loss of ₹78.41 lacs on 30th Sep'25, driving basic and diluted EPS to ₹2.50 from negative ₹0.63. Additionally, the board approved granting 186,720 ESOPs at ₹10 face value and appointed Abhash Dilip Meswani as Whole-Time Director and Vice President – Xelix for five years.

Original exchange filing (PDF)

More announcements from Aakaar Medical Technologies Ltd

All Aakaar Medical Technologies Ltd announcements